Target Gene/Pathway(薬物標的遺伝子/パスウェイリスト)

e.g. "Sirolimus", "アダリムマブ", "MAP2K"

ABCDEFGH I JKLMNOPQRSTUVWXYZother

37 / 286 pathways

No. KEGG PATHWAY   💬 Info on mouse-over
On map, Yellow: Drug target, Red: All disease-related
KEGG GENES
💬 Info on mouse-over
KEGG DRUG
💬 Info on mouse-over
DrugBank 指定難病告示番号
💬 Info on mouse-over
1 Allograft rejection 💬
2件: CD80, CD86 💬 D03203 💬 Abatacept 26件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬
2 Allograft rejection 💬
1件: IL5 💬 D04923 💬 Mepolizumab 4件: 44, 45, 98, 162 💬
3 Allograft rejection 💬
1件: IL5 💬 D08985 💬 Reslizumab 2件: 44, 98 💬
4 Antifolate resistance 💬
2件: DHFR, DHFR2 💬 D00142 💬 Methotrexate 35件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 271, 284, 285, 326, 331 💬
5 Antifolate resistance 💬
2件: DHFR, DHFR2 💬 D02115 💬 Methotrexate 35件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 271, 284, 285, 326, 331 💬
6 Asthma 💬
1件: IL5 💬 D04923 💬 Mepolizumab 4件: 44, 45, 98, 162 💬
7 Asthma 💬
1件: IL5 💬 D08985 💬 Reslizumab 2件: 44, 98 💬
8 Autoimmune thyroid disease 💬
2件: CD80, CD86 💬 D03203 💬 Abatacept 26件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬
9 Autoimmune thyroid disease 💬
1件: IL5 💬 D04923 💬 Mepolizumab 4件: 44, 45, 98, 162 💬
10 Autoimmune thyroid disease 💬
1件: IL5 💬 D08985 💬 Reslizumab 2件: 44, 98 💬
11 Biosynthesis of cofactors 💬
2件: DHFR, DHFR2 💬 D00142 💬 Methotrexate 35件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 271, 284, 285, 326, 331 💬
12 Biosynthesis of cofactors 💬
2件: DHFR, DHFR2 💬 D02115 💬 Methotrexate 35件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 271, 284, 285, 326, 331 💬
13 Cell adhesion molecules 💬
2件: CD80, CD86 💬 D03203 💬 Abatacept 26件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬
14 cGMP-PKG signaling pathway 💬
1件: OPRD1 💬 D02095 💬 Naltrexone 13件: 6, 10, 13, 40, 41, 42, 43, 44, 45, 46, 96, 97, 226 💬
15 cGMP-PKG signaling pathway 💬
1件: OPRD1 💬 D05113 💬 Naltrexone 13件: 6, 10, 13, 40, 41, 42, 43, 44, 45, 46, 96, 97, 226 💬
16 Complement and coagulation cascades 💬
1件: C5AR1 💬 D11093 💬 Avacopan 4件: 43, 44, 222, 223 💬
17 Coronavirus disease - COVID-19 💬
1件: C5AR1 💬 D11093 💬 Avacopan 4件: 43, 44, 222, 223 💬
18 Cytokine-cytokine receptor interaction 💬
1件: IL5 💬 D04923 💬 Mepolizumab 4件: 44, 45, 98, 162 💬
19 Cytokine-cytokine receptor interaction 💬
1件: IL5 💬 D08985 💬 Reslizumab 2件: 44, 98 💬
20 Cytokine-cytokine receptor interaction 💬
1件: IL5RA 💬 D09874 💬 Benralizumab 4件: 44, 45, 98, 162 💬
21 Cytokine-cytokine receptor interaction 💬
1件: TNFSF13B 💬 D03068 💬 Belimumab 10件: 11, 43, 44, 46, 49, 51, 53, 66, 222, 300 💬
22 Estrogen signaling pathway 💬
1件: OPRM1 💬 D02095 💬 Naltrexone 13件: 6, 10, 13, 40, 41, 42, 43, 44, 45, 46, 96, 97, 226 💬
23 Estrogen signaling pathway 💬
1件: OPRM1 💬 D05113 💬 Naltrexone 13件: 6, 10, 13, 40, 41, 42, 43, 44, 45, 46, 96, 97, 226 💬
24 Fc epsilon RI signaling pathway 💬
1件: IL5 💬 D04923 💬 Mepolizumab 4件: 44, 45, 98, 162 💬
25 Fc epsilon RI signaling pathway 💬
1件: IL5 💬 D08985 💬 Reslizumab 2件: 44, 98 💬
26 Folate biosynthesis 💬
2件: DHFR, DHFR2 💬 D00142 💬 Methotrexate 35件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 271, 284, 285, 326, 331 💬
27 Folate biosynthesis 💬
2件: DHFR, DHFR2 💬 D02115 💬 Methotrexate 35件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 271, 284, 285, 326, 331 💬
28 Graft-versus-host disease 💬
2件: CD80, CD86 💬 D03203 💬 Abatacept 26件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬
29 Hematopoietic cell lineage 💬
1件: IL5 💬 D04923 💬 Mepolizumab 4件: 44, 45, 98, 162 💬
30 Hematopoietic cell lineage 💬
1件: IL5 💬 D08985 💬 Reslizumab 2件: 44, 98 💬
31 Hematopoietic cell lineage 💬
1件: IL5RA 💬 D09874 💬 Benralizumab 4件: 44, 45, 98, 162 💬
32 Hematopoietic cell lineage 💬
1件: MS4A1 💬 D02994 💬 Rituximab 47件: 11, 13, 14, 17, 19, 35, 36, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
33 IL-17 signaling pathway 💬
1件: IL5 💬 D04923 💬 Mepolizumab 4件: 44, 45, 98, 162 💬
34 IL-17 signaling pathway 💬
1件: IL5 💬 D08985 💬 Reslizumab 2件: 44, 98 💬
35 Inflammatory bowel disease 💬
1件: IL5 💬 D04923 💬 Mepolizumab 4件: 44, 45, 98, 162 💬
36 Inflammatory bowel disease 💬
1件: IL5 💬 D08985 💬 Reslizumab 2件: 44, 98 💬
37 Intestinal immune network for IgA production 💬
2件: CD80, CD86 💬 D03203 💬 Abatacept 26件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬
38 Intestinal immune network for IgA production 💬
1件: IL5 💬 D04923 💬 Mepolizumab 4件: 44, 45, 98, 162 💬
39 Intestinal immune network for IgA production 💬
1件: IL5 💬 D08985 💬 Reslizumab 2件: 44, 98 💬
40 Intestinal immune network for IgA production 💬
1件: TNFSF13B 💬 D03068 💬 Belimumab 10件: 11, 43, 44, 46, 49, 51, 53, 66, 222, 300 💬
41 JAK-STAT signaling pathway 💬
1件: IL5 💬 D04923 💬 Mepolizumab 4件: 44, 45, 98, 162 💬
42 JAK-STAT signaling pathway 💬
1件: IL5 💬 D08985 💬 Reslizumab 2件: 44, 98 💬
43 JAK-STAT signaling pathway 💬
1件: IL5RA 💬 D09874 💬 Benralizumab 4件: 44, 45, 98, 162 💬
44 Kaposi sarcoma-associated herpesvirus infection 💬
1件: CD86 💬 D03203 💬 Abatacept 26件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬
45 Metabolic pathways 💬
2件: DHFR, DHFR2 💬 D00142 💬 Methotrexate 35件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 271, 284, 285, 326, 331 💬
46 Metabolic pathways 💬
2件: DHFR, DHFR2 💬 D02115 💬 Methotrexate 35件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 271, 284, 285, 326, 331 💬
47 Morphine addiction 💬
1件: OPRM1 💬 D02095 💬 Naltrexone 13件: 6, 10, 13, 40, 41, 42, 43, 44, 45, 46, 96, 97, 226 💬
48 Morphine addiction 💬
1件: OPRM1 💬 D05113 💬 Naltrexone 13件: 6, 10, 13, 40, 41, 42, 43, 44, 45, 46, 96, 97, 226 💬
49 Neuroactive ligand-receptor interaction 💬
1件: C5AR1 💬 D11093 💬 Avacopan 4件: 43, 44, 222, 223 💬
50 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 D00472 💬 Prednisolone 40件: 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬
51 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 D00980 💬 Prednisolone 40件: 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬
52 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 D00981 💬 Prednisolone 40件: 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬
53 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 D00982 💬 Prednisolone 40件: 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬
54 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 D01239 💬 Prednisolone 40件: 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬
55 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 D01998 💬 Prednisolone 40件: 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬
56 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 D02156 💬 Prednisolone 40件: 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬
57 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 D03301 💬 Prednisolone 40件: 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬
58 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 D00473 💬 Prednisone 47件: 2, 6, 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 81, 84, 85, 86, 93, 95, 96, 97, 113, 127, 162, 164, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 💬
59 Neuroactive ligand-receptor interaction 💬
3件: OPRD1, OPRK1, OPRM1 💬 D02095 💬 Naltrexone 13件: 6, 10, 13, 40, 41, 42, 43, 44, 45, 46, 96, 97, 226 💬
60 Neuroactive ligand-receptor interaction 💬
3件: OPRD1, OPRK1, OPRM1 💬 D05113 💬 Naltrexone 13件: 6, 10, 13, 40, 41, 42, 43, 44, 45, 46, 96, 97, 226 💬
61 Neutrophil extracellular trap formation 💬
1件: C5AR1 💬 D11093 💬 Avacopan 4件: 43, 44, 222, 223 💬
62 NF-kappa B signaling pathway 💬
1件: TNFSF13B 💬 D03068 💬 Belimumab 10件: 11, 43, 44, 46, 49, 51, 53, 66, 222, 300 💬
63 One carbon pool by folate 💬
2件: DHFR, DHFR2 💬 D00142 💬 Methotrexate 35件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 271, 284, 285, 326, 331 💬
64 One carbon pool by folate 💬
2件: DHFR, DHFR2 💬 D02115 💬 Methotrexate 35件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 271, 284, 285, 326, 331 💬
65 Pathways in cancer 💬
1件: IL5 💬 D04923 💬 Mepolizumab 4件: 44, 45, 98, 162 💬
66 Pathways in cancer 💬
1件: IL5 💬 D08985 💬 Reslizumab 2件: 44, 98 💬
67 Pathways in cancer 💬
1件: IL5RA 💬 D09874 💬 Benralizumab 4件: 44, 45, 98, 162 💬
68 Rheumatoid arthritis 💬
2件: CD80, CD86 💬 D03203 💬 Abatacept 26件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬
69 Rheumatoid arthritis 💬
1件: TNFSF13B 💬 D03068 💬 Belimumab 10件: 11, 43, 44, 46, 49, 51, 53, 66, 222, 300 💬
70 Sphingolipid signaling pathway 💬
1件: OPRD1 💬 D02095 💬 Naltrexone 13件: 6, 10, 13, 40, 41, 42, 43, 44, 45, 46, 96, 97, 226 💬
71 Sphingolipid signaling pathway 💬
1件: OPRD1 💬 D05113 💬 Naltrexone 13件: 6, 10, 13, 40, 41, 42, 43, 44, 45, 46, 96, 97, 226 💬
72 Staphylococcus aureus infection 💬
1件: C5AR1 💬 D11093 💬 Avacopan 4件: 43, 44, 222, 223 💬
73 Systemic lupus erythematosus 💬
2件: CD80, CD86 💬 D03203 💬 Abatacept 26件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬
74 T cell receptor signaling pathway 💬
1件: IL5 💬 D04923 💬 Mepolizumab 4件: 44, 45, 98, 162 💬
75 T cell receptor signaling pathway 💬
1件: IL5 💬 D08985 💬 Reslizumab 2件: 44, 98 💬
76 Th1 and Th2 cell differentiation 💬
1件: IL5 💬 D04923 💬 Mepolizumab 4件: 44, 45, 98, 162 💬
77 Th1 and Th2 cell differentiation 💬
1件: IL5 💬 D08985 💬 Reslizumab 2件: 44, 98 💬
78 Toll-like receptor signaling pathway 💬
2件: CD80, CD86 💬 D03203 💬 Abatacept 26件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬
79 Transcriptional misregulation in cancer 💬
1件: CD86 💬 D03203 💬 Abatacept 26件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬
80 Type I diabetes mellitus 💬
2件: CD80, CD86 💬 D03203 💬 Abatacept 26件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬
81 Viral myocarditis 💬
2件: CD80, CD86 💬 D03203 💬 Abatacept 26件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬